| Literature DB >> 33101594 |
David Ríos1, Jaime A Valderrama1, Miriam Cautin1, Milko Tapia1, Felipe Salas1, Angélica Guerrero-Castilla1, Giulio G Muccioli2, Pedro Buc Calderón1,3, Julio Benites1.
Abstract
The reaction of 2-acyl-1,4-naphthoquinones with N,N-dimethylaniline and 2,5-dimethoxyaniline, promoted by catalytic amounts of CeCl3·7H2O under "open-flask" conditions, produced a variety of 2-acyl-3-aminophenyl-1,4-naphthoquinones structurally related to the cytotoxic 2-acetyl-3-phenyl-1,4-naphthoquinone, an inhibitor of the heat shock chaperone protein Hsp90. The members of the 2-acyl-3-aminophenyl-1,4-naphthoquinone series were isolated in good yields (63-98%). The cyclic voltammograms of the 2-acyl-3-aminophenyl-1,4-naphthoquinone exhibit two one-electron reduction waves to the corresponding radical-anion and dianion and two quasireversible oxidation peaks. The first and second half-wave potential values (E 1/2) of the members of the series are sensitive to the push-pull electronic effects of the substituents in the naphthoquinone scaffold. Furthermore, the in vitro antiproliferative properties of these new quinones were evaluated on two human cancer cells DU-145 (prostate) and MCF-7 (mammary) and a nontumorigenic HEK-293 (kidney) cell line, using the MTT colorimetric method. Two members, within the series, exhibited interesting cytotoxic activities on human prostate and mammary cancer cells.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33101594 PMCID: PMC7574025 DOI: 10.1155/2020/8939716
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Examples of naphthoquinone-containing compounds prepared from acylquinones.
Figure 2Structure of HTS1/HTS3 and quinone-analogue inhibitors of Hsp90.
Scheme 1Formation of 2-acetyl-3-aminophenyl-1,4-naphthoquinones. Adapted from [24].
Synthesis of 2-acyl-3-aminophenylnaphthoquinones 16-28 from 2-acylnaphthoquinones 9-15, N, N-dimethylaniline and 2,5-dimethoxyaniline.
| Acylquinone | Product | Structure | Time(hrs) | Yield(%)∗ |
|---|---|---|---|---|
| 10 | 16 |
| 3 | 65 |
| 11 | 17 |
| 5 | 33 |
| 12 | 18 |
| 240 | 91 |
| 13 | 19 |
| 216 | 81 |
| 14 | 20 |
| 28 | 98 |
| 15 | 21 |
| 72 | 94 |
| 9 | 22 |
| 48 | 77 |
| 10 | 23 |
| 1.5 | 63 |
| 11 | 24 |
| 2 | 63 |
| 12 | 25 |
| 4 | 91 |
| 13 | 26 |
| 3 | 87 |
| 14 | 27 |
| 2.5 | 83 |
| 15 | 28 |
| 2 | 91 |
∗ Isolated by column chromatography. Yields are based on the corresponding acetylnaphthohydroquinones 2-8.
Scheme 2Preparation of 2-acylnaphthoquinones 9-15 from 1 and diverse aldehydes.
Scheme 3Proposed reaction mechanism for the Ce(III)-promoted arylation reaction of acylnaphtoquinones with N,N-dimethylaniline.
Figure 3Hybrid and 3-D optimized structure of compounds 16 and 23.
Figure 4Typical cyclic voltammogram of compound 23 in 0.1 M Et4NBF4/acetonitrile obtained in Pt electrode, scan rate 100 mV/s. The cathodic (c) and anodic (a) peaks are indicated in the figure.
Half-wave potential values EI1/2 and EII1/2 of 2-acyl-3-aminophenylnaphthoquinones 16-28.
| Product no. | R | − | − |
|---|---|---|---|
| 16 | C3H7 | 790 | 1180 |
| 17 | C5H11 | 875 | 1295 |
| 18 | 4-MeOPh | 815 | 1190 |
| 19 | 2,5-(OMe)2Ph | 845 | 1165 |
| 20 | 2-Furyl | 620 | 1125 |
| 21 | 2-Thienyl | 775 | 1165 |
| 22 | CH3 | 890 | 1410 |
| 23 | C3H7 | 685 | 1180 |
| 24 | C5H11 | 755 | 1230 |
| 25 | 4-MeOPh | 720 | 1225 |
| 26 | 2,5-(OMe)2Ph | 760 | 1225 |
| 27 | 2-Furyl | 710 | 1200 |
| 28 | 2-Thienyl | 700 | 1205 |
IC50 ± SEM (μM) values of 16–28 on DU-145 (prostate cancer cells) and MCF-7 (mammary cancer cells) and nontumorigenic HEK-293 (embryonic kidney cells)∗.
| Compound no. | R | DU-145 | MCF-7 | Mean value | HEK-293 |
|---|---|---|---|---|---|
| 16 | C3H7 | 77.8 ± 1.1 | >100 | - | 51.1 ± 0.8 |
| 17 | C5H11 | >100 | >100 | - | 77.4 ± 0.6 |
| 18 | 4-MeOPh | >100 | >100 | - | >100 |
| 19 | 2,5-(OMe)2Ph | >100 | >100 | - | >100 |
| 20 | 2-Furyl | 36.5 ± 0.2 | >100 | - | 35.1 ± 1.4 |
| 21 | 2-Thienyl | 53.1 ± 5.0 | >100 | - | 67.6 ± 2.5 |
| 22 | CH3 | 12.3 ± 0.4 | 21.2 ± 0.3 | 16.7 | 28.6 ± 1.9 |
| 23 | C3H7 | 22.5 ± 0.2 | 23.3 ± 0.5 | 22.9 | 21.5 ± 0.7 |
| 24 | C5H11 | 54.6 ± 1.5 | >100 | - | 58.4 ± 0.6 |
| 25 | 4-MeOPh | >100 | 73.5 ± 1.6 | - | 71.3 ± 1.2 |
| 26 | 2,5-(OMe)2Ph | 28.7 ± 0.7 | 74.1 ± 2.4 | 51.4 | 53.3 ± 1.2 |
| 27 | 2-Furyl | 13.2 ± 1.1 | 21.2 ± 1.4 | 17.2 | 11.2 ± 0.7 |
| 28 | 2-Thienyl | 24.8 ± 0.3 | 33.1 ± 1.6 | 28.9 | 22.9 ± 0.7 |
| DOX | - | 0.70 ± 0.02 | 0.05 ± 0.003 | - | 4.27 ± 0.34 |
∗Cells were incubated at 37°C for 48 h, with or without quinone derivatives. Afterwards, aliquots of cell suspensions were taken and the MTT test was performed, as described in Materials and Methods. Results are expressed as mean values ± SEM (n = 3). DOX = doxorubicin.